Know Cancer

or
forgot password

A Phase II Feasibility Study of Cone Beam Computed Tomography for Daily Image Guidance in Patients Receiving Dose Escalated Conformal Radiation Therapy for Prostate Cancer


Phase 2
18 Years
N/A
Not Enrolling
Male
Prostatic Neoplasms

Thank you

Trial Information

A Phase II Feasibility Study of Cone Beam Computed Tomography for Daily Image Guidance in Patients Receiving Dose Escalated Conformal Radiation Therapy for Prostate Cancer


Inclusion Criteria:



- Diagnosis of adenocarcinoma of the prostate

- Patient undergoing dose escalated conformal external beam radiation therapy

- Low or intermediate risk prognostic factors (PSA 20 or less, Gleason score <8,
Clinical T category
- Age 18 years or older

- ECOG performance status 0 or 1

- Informed consent

Exclusion Criteria:

- Inflammatory bowel disease or collagen vascular disease

Type of Study:

Interventional

Study Design:

Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Outcome Measure:

To evaluate the feasibility of cone beam CT for daily on-line image guidance in patients receiving conformal radiation therapy for prostate cancer.

Principal Investigator

Charles Catton, MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

Princess Margaret Hospital, Canada

Authority:

Canada: Ethics Review Committee

Study ID:

UHN REB 05-0037-C

NCT ID:

NCT00188786

Start Date:

April 2005

Completion Date:

April 2010

Related Keywords:

  • Prostatic Neoplasms
  • Neoplasms
  • Prostatic Neoplasms

Name

Location